Omnicell [OMCL] vs Phreesia [PHR] Detailed Stock Comparison
Omnicell
NASDAQ
Loading...
Phreesia
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Omnicell wins in 11 metrics, Phreesia wins in 6 metrics, with 0 ties. Omnicell appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Omnicell | Phreesia | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 66.90 | N/A | N/A |
| Price-to-Book Ratio | 1.18 | 5.34 | Omnicell |
| Debt-to-Equity Ratio | 30.42 | 2.60 | Phreesia |
| PEG Ratio | 1.34 | -40.10 | Phreesia |
| EV/EBITDA | 19.72 | -27.85 | Phreesia |
| Profit Margin (TTM) | 2.01% | -13.94% | Omnicell |
| Operating Margin (TTM) | 2.80% | -46.68% | Omnicell |
| EBITDA Margin (TTM) | 2.80% | N/A | N/A |
| Return on Equity | 1.87% | -22.67% | Omnicell |
| Return on Assets (TTM) | 0.49% | -8.75% | Omnicell |
| Free Cash Flow (TTM) | $134.93M | $8.29M | Omnicell |
| 1-Year Return | -29.10% | 19.45% | Phreesia |
| Price-to-Sales Ratio (TTM) | 1.32 | 3.41 | Omnicell |
| Enterprise Value | $1.46B | $986.85M | Omnicell |
| EV/Revenue Ratio | 1.27 | 2.35 | Omnicell |
| Gross Profit Margin (TTM) | 43.94% | 69.40% | Phreesia |
| Revenue per Share (TTM) | $25 | $7 | Omnicell |
| Earnings per Share (Diluted) | $0.48 | $-1.02 | Omnicell |
| Beta (Stock Volatility) | 0.82 | 0.74 | Phreesia |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Omnicell vs Phreesia Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Omnicell | -3.05% | -1.47% | 5.28% | 4.02% | -15.10% | -27.55% |
| Phreesia | -9.87% | -11.15% | 3.80% | 9.12% | 9.16% | 11.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Omnicell | -29.10% | -69.52% | -55.32% | -5.28% | 177.53% | 210.84% |
| Phreesia | 19.45% | -1.51% | -0.07% | 17.21% | 17.21% | 17.21% |
Performance & Financial Health Analysis: Omnicell vs Phreesia
| Metric | OMCL | PHR |
|---|---|---|
| Market Information | ||
| Market Cap | $1.52B | $1.43B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 511,354 | 403,230 |
| 90 Day Avg. Volume | 583,758 | 422,913 |
| Last Close | $32.11 | $28.13 |
| 52 Week Range | $22.66 - $55.75 | $17.07 - $32.76 |
| % from 52W High | -42.40% | -14.13% |
| All-Time High | $187.29 (Nov 22, 2021) | $81.59 (Feb 08, 2021) |
| % from All-Time High | -82.86% | -65.52% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.05% | 0.46% |
| Quarterly Earnings Growth | 0.51% | 0.15% |
| Financial Health | ||
| Profit Margin (TTM) | 0.02% | -0.14% |
| Operating Margin (TTM) | 0.03% | -0.47% |
| Return on Equity (TTM) | 0.02% | -0.23% |
| Debt to Equity (MRQ) | 30.42 | 2.60 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $27.22 | $4.51 |
| Cash per Share (MRQ) | $8.69 | $7.48 |
| Operating Cash Flow (TTM) | $147.75M | $32.38M |
| Levered Free Cash Flow (TTM) | $85.81M | $28.64M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: Omnicell vs Phreesia
| Metric | OMCL | PHR |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 66.90 | N/A |
| Forward P/E | 17.84 | -40.10 |
| PEG Ratio | 1.34 | -40.10 |
| Price to Sales (TTM) | 1.32 | 3.41 |
| Price to Book (MRQ) | 1.18 | 5.34 |
| Market Capitalization | ||
| Market Capitalization | $1.52B | $1.43B |
| Enterprise Value | $1.46B | $986.85M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.27 | 2.35 |
| Enterprise to EBITDA | 19.72 | -27.85 |
| Risk & Other Metrics | ||
| Beta | 0.82 | 0.74 |
| Book Value per Share (MRQ) | $27.22 | $4.51 |
Financial Statements Comparison: Omnicell vs Phreesia
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | OMCL | PHR |
|---|---|---|
| Revenue/Sales | $290.56M | $109.68M |
| Cost of Goods Sold | $162.88M | $33.57M |
| Gross Profit | $127.68M | $76.12M |
| Research & Development | $21.57M | $29.63M |
| Operating Income (EBIT) | $8.12M | $-7.61M |
| EBITDA | $29.77M | $2.03M |
| Pre-Tax Income | $10.45M | $-5.38M |
| Income Tax | $4.81M | $1.01M |
| Net Income (Profit) | $5.64M | $-6.39M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | OMCL | PHR |
|---|---|---|
| Cash & Equivalents | $386.83M | $84.22M |
| Total Current Assets | $839.67M | $203.29M |
| Total Current Liabilities | $607.53M | $114.02M |
| Long-Term Debt | $199.72M | $8.80M |
| Total Shareholders Equity | $1.26B | $264.81M |
| Retained Earnings | $375.87M | $-801.50M |
| Property, Plant & Equipment | $130.63M | $17.24M |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | OMCL | PHR |
|---|---|---|
| Operating Cash Flow | $28.34M | $15.59M |
| Capital Expenditures | $-11.17M | $-2.79M |
| Free Cash Flow | $10.19M | $9.20M |
| Debt Repayment | N/A | $-2.64M |
| Common Stock Repurchase | N/A | $0 |
Short Interest & Institutional Ownership Analysis
| Metric | OMCL | PHR |
|---|---|---|
| Shares Short | 2.04M | 2.34M |
| Short Ratio | 3.41 | 4.77 |
| Short % of Float | 0.06% | 0.05% |
| Average Daily Volume (10 Day) | 511,354 | 403,230 |
| Average Daily Volume (90 Day) | 583,758 | 422,913 |
| Shares Outstanding | 46.38M | 58.73M |
| Float Shares | 44.82M | 56.03M |
| % Held by Insiders | 0.02% | 0.04% |
| % Held by Institutions | 1.06% | 0.97% |
Dividend Analysis & Yield Comparison: Omnicell vs Phreesia
| Metric | OMCL | PHR |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.00 |
| 3-Year Avg Dividend Yield | N/A | N/A |
| 3-Year Total Dividends | N/A | $0.00 |
| Ex-Dividend Date | N/A | N/A |